Cite
Rapid and early virological response to chronic hepatitis C treatment with IFN (alpha)2b or PEG-IFN (alpha)2b plus ribavirin in HIV/HCV co-infected patients
MLA
Payan, Christopher, et al. “Rapid and Early Virological Response to Chronic Hepatitis C Treatment with IFN (Alpha)2b or PEG-IFN (Alpha)2b plus Ribavirin in HIV/HCV Co-Infected Patients.” Gut, vol. 56, no. 8, Aug. 2007, p. 1111. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.168643472&authtype=sso&custid=ns315887.
APA
Payan, C., Pivert, A., Morand, P., Fafi-Kremer, S., Carrat, F., Pol, S., Cacoub, P., Perronne, C., & Lunel, F. (2007). Rapid and early virological response to chronic hepatitis C treatment with IFN (alpha)2b or PEG-IFN (alpha)2b plus ribavirin in HIV/HCV co-infected patients. Gut, 56(8), 1111.
Chicago
Payan, Christopher, Adeline Pivert, Patrice Morand, Samira Fafi-Kremer, Fabrice Carrat, Stanislas Pol, Patrice Cacoub, Christian Perronne, and Francoise Lunel. 2007. “Rapid and Early Virological Response to Chronic Hepatitis C Treatment with IFN (Alpha)2b or PEG-IFN (Alpha)2b plus Ribavirin in HIV/HCV Co-Infected Patients.” Gut 56 (8): 1111. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.168643472&authtype=sso&custid=ns315887.